Mitoxantrone in combination with an inhibitor of DNA-dependent protein kinase: A potential therapy for poor risk B-cell chronic lymphocytic leukaemia

被引：0
|
作者：
Elliott, S. L. [1 ]
Crawford, C. W. [1 ]
Summerfield, G. P. [2 ]
Newton, P. [3 ]
Wallis, J. [2 ]
Mainou-Fowler, T. [2 ]
Evans, P. [4 ]
Bedwell, C. [5 ]
Durkacz, B. W. [1 ]
Willmore, E. [1 ]
机构：
[1] Univ Newcastle, No Inst Canc Res, Newcastle Upon Tyne, Tyne & Wear, England
[2] Univ Newcastle, Dept Acad Haematol, Newcastle Upon Tyne, Tyne & Wear, England
[3] Sunderland Royal Hosp, Sunderland, England
[4] St James Univ Hosp, Leeds LS9 7TF, W Yorkshire, England
[5] Newcastle Tyne NHS Hosp Trust, No Genet Serv, Newcastle Upon Tyne, Tyne & Wear, England
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2010年 / 149卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
227
引用
收藏
页码：90 / 90
页数：1
相关论文
共 50 条
  • [21] CD31 density is a new risk factor for patients with B-cell chronic lymphocytic leukaemia
    Mainou-Fowler, T.
    Porteous, A.
    Nicolle, A.
    Proctor, S. J.
    Anderson, J.
    Summerfield, G.
    ANNALS OF ONCOLOGY, 2008, 19 : 192 - 192
  • [22] CD31 density is a novel risk factor for patients with B-cell chronic lymphocytic leukaemia
    Mainou-Fowler, Tryfonia
    Porteous, Alistair
    Nicolle, Annette
    Proctor, Stephen John
    Anderson, John James
    Summerfield, Geoffrey
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2008, 33 (01) : 169 - 174
  • [23] DNA-dependent protein kinase activity correlates with clinical and in vitro sensitivity of chronic lymphocytic leukemia lymphocytes to nitrogen mustards
    Muller, C
    Christodoulopoulos, G
    Salles, B
    Panasci, L
    BLOOD, 1998, 92 (07) : 2213 - 2219
  • [24] Mutational analysis of the cyclin-dependent kinase inhibitor p27 in chronic B-cell lymphocytic leukemia (B-CLL).
    Pappa, V
    Douka, E
    Kontsioti, F
    Economopoulos, T
    Bakiri, M
    Dervenoulas, J
    Tsirigotis, P
    Mantzios, G
    Papageorgiou, E
    Raptis, S
    BLOOD, 2000, 96 (11) : 750A - 750A
  • [25] VARIABLE B-CELL SUBSET DEPLETION IN CHRONIC LYMPHOCYTIC LEUKAEMIA: SERUM IMMUNOGLOBULIN LEVELS ARE A POOR PREDICTOR OF IMMUNE COMPETENCE
    Dalal, Surita
    De Tute, Ruth
    Denman, Selina
    Hillmen, Peter
    Jack, Andrew
    Rawstron, Andy
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2011, 80B (06) : 418 - 418
  • [26] Tcl1 protein functions as an inhibitor of de novo DNA methylation in B-cell chronic lymphocytic leukemia (CLL)
    Palamarchuk, Alexey
    Yan, Pearlly S.
    Zanesi, Nicola
    Wang, Linan
    Rodrigues, Benjamin
    Murphy, Mark
    Balatti, Veronica
    Bottoni, Arianna
    Nazaryan, Natalya
    Alder, Hansjuerg
    Rassenti, Laura
    Kipps, Thomas J.
    Freitas, Michael
    Croce, Carlo M.
    Pekarsky, Yuri
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (07) : 2555 - 2560
  • [27] Positive regulation of deoxycytidine kinase activity by phosphorylation of Ser-74 in B-cell chronic lymphocytic leukaemia lymphocytes
    Smal, Caroline
    Van Den Neste, Eric
    Maerevoet, Marie
    Poire, Xavier
    Theate, Ivan
    Bontemps, Francoise
    CANCER LETTERS, 2007, 253 (01) : 68 - 73
  • [28] Flavopiridol induces apoptosis in B-cell chronic lymphocytic leukaemia cells through a p38 and ERK MAP kinase-dependent mechanism
    Pepper, C
    Thomas, A
    Fegan, C
    Hoy, T
    Bentley, P
    LEUKEMIA & LYMPHOMA, 2003, 44 (02) : 337 - 342
  • [29] The DNA-dependent protein kinase (DNA-PK) activity is determinant in the response of chronic lymphocytic leukemia (CLL) lymphocytes to nitrogen mustards (NMs).
    Muller, C
    Christodoulopoulos, G
    Salles, B
    Panasci, L
    BLOOD, 1998, 92 (10) : 385A - 385A
  • [30] Fulminant B hepatitis in a surface antigen-negative patient with B-cell chronic lymphocytic leukaemia after rituximab therapy
    Niscola, P
    Del Principe, MI
    Maurillo, L
    Venditti, A
    Buccisano, F
    Piccioni, D
    Amadori, S
    Del Poeta, G
    LEUKEMIA, 2005, 19 (10) : 1840 - 1841
12345